Trial Profile
A study evaluating burden of acnitic keratosis (AK) treatment on health related quality of life (HRQoL).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Apr 2017
Price :
$35
*
At a glance
- Drugs Ingenol mebutate (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- 06 Apr 2017 New trial record